Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$9,161,205
+$1,783,727 QoQ
Shares Held
36,406
+7.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#968
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURNS J W & CO INC/NY holds $40,501,690 across 10 Drug Manufacturers - General names. ABBV ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
53,495 | $13,586,125 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
36,406 | $9,161,205 | |
| 3 | AMGN |
Amgen Inc
|
22,691 | $8,216,864 | |
| 4 | LLY |
ELI LILLY & Co
|
4,335 | $5,199,529 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,774 | $1,542,717 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,012 | $901,042 | |
| 7 | NVS |
Novartis AG
|
4,915 | $770,278 | |
| 8 | PFE |
Pfizer Inc
|
29,042 | $699,331 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,161,205 | 36,406 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $7,377,478 | 33,921 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $7,717,935 | 33,778 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $7,939,738 | 34,291 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $6,360,454 | 34,266 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $6,968,844 | 33,261 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $5,764,765 | 32,441 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $6,427,381 | 32,547 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $5,704,412 | 33,258 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $5,922,438 | 32,523 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $4,955,630 | 31,978 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $4,814,190 | 32,297 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,349,623 | 32,284 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $5,153,866 | 32,339 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $5,118,350 | 31,671 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,230,701 | 31,523 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $4,623,594 | 30,188 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $4,586,902 | 28,295 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $4,238,020 | 31,300 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,036,864 | 28,153 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,126,097 | 27,753 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $3,025,722 | 27,959 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $2,967,090 | 27,691 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,379,031 | 27,161 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $2,666,666 | 27,161 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $2,008,901 | 26,367 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||